AAAAAA

   
Results: 1-25 | 26-50 | 51-72
Results: 1-25/72
EFFICIENT TRANSDUCTION OF NONDIVIDING HUMAN-CELLS BY FELINE IMMUNODEFICIENCY VIRUS LENTIVIRAL VECTORS
Authors: POESCHLA EM WONGSTAAL F LOONEY DJ
Citation: Em. Poeschla et al., EFFICIENT TRANSDUCTION OF NONDIVIDING HUMAN-CELLS BY FELINE IMMUNODEFICIENCY VIRUS LENTIVIRAL VECTORS, Nature medicine, 4(3), 1998, pp. 354-357
A CONTROLLED, PHASE-1 CLINICAL-TRIAL TO EVALUATE THE SAFETY AND EFFECTS IN HIV-1-INFECTED HUMANS OF AUTOLOGOUS LYMPHOCYTES TRANSDUCED WITH A RIBOZYME THAT CLEAVES HIV-1 RNA
Authors: WONGSTAAL F POESCHLA EM LOONEY DJ
Citation: F. Wongstaal et al., A CONTROLLED, PHASE-1 CLINICAL-TRIAL TO EVALUATE THE SAFETY AND EFFECTS IN HIV-1-INFECTED HUMANS OF AUTOLOGOUS LYMPHOCYTES TRANSDUCED WITH A RIBOZYME THAT CLEAVES HIV-1 RNA, Human gene therapy, 9(16), 1998, pp. 2407-2425
DEVELOPMENT OF NOVEL CELL-SURFACE CD34-TARGETED RECOMBINANT ADENOASSOCIATED VIRUS VECTORS FOR GENE-THERAPY
Authors: YANG QC MAMOUNAS M YU G KENNEDY S LEAKER B MERSON J WONGSTAAL F YU M BARBER JR
Citation: Qc. Yang et al., DEVELOPMENT OF NOVEL CELL-SURFACE CD34-TARGETED RECOMBINANT ADENOASSOCIATED VIRUS VECTORS FOR GENE-THERAPY, Human gene therapy, 9(13), 1998, pp. 1929-1937
GENE-THERAPY TARGETING CORD BLOOD-DERIVED CD34(-EXPOSED INFANTS - PRECLINICAL STUDIES() CELLS FROM HIV)
Authors: LI X GERVAIX A KANG D LAW P SPECTOR SA HO AD WONGSTAAL F
Citation: X. Li et al., GENE-THERAPY TARGETING CORD BLOOD-DERIVED CD34(-EXPOSED INFANTS - PRECLINICAL STUDIES() CELLS FROM HIV), Gene therapy, 5(2), 1998, pp. 233-239
TRANSDUCTION OF HUMAN MACROPHAGES USING A STABLE HIV-1 HIV-2-DERIVED GENE DELIVERY SYSTEM/
Authors: CORBEAU P KRAUS G WONGSTAAL F
Citation: P. Corbeau et al., TRANSDUCTION OF HUMAN MACROPHAGES USING A STABLE HIV-1 HIV-2-DERIVED GENE DELIVERY SYSTEM/, Gene therapy, 5(1), 1998, pp. 99-104
EXPRESSION OF RIBOZYMES IN GENE-TRANSFER SYSTEMS TO MODULATE TARGET RNA LEVELS
Authors: WELCH PJ BARBER JR WONGSTAAL F
Citation: Pj. Welch et al., EXPRESSION OF RIBOZYMES IN GENE-TRANSFER SYSTEMS TO MODULATE TARGET RNA LEVELS, Current opinion in biotechnology, 9(5), 1998, pp. 486-496
CHARACTERIZATION OF A MOLECULAR CLONE OF HIV TYPE-2 INFECTIOUS FOR MACACA-NEMESTRINA
Authors: KRAUS G RADAELLI A TALBOTT R LEAVITT M SCHMIDT A BADEL P BARTZ C MORTON W WONGSTAAL F LOONEY DJ
Citation: G. Kraus et al., CHARACTERIZATION OF A MOLECULAR CLONE OF HIV TYPE-2 INFECTIOUS FOR MACACA-NEMESTRINA, AIDS research and human retroviruses, 14(1), 1998, pp. 65-77
MATURE MONOCYTE-DERIVED DENDRITIC CELLS TRANSDUCED BY A REPLICATION-DEFICIENT HIV-1 VECTOR ARE CAPABLE OF GENERATING HIV-SPECIFIC CYTOTOXICT-CELLS IN CULTURE
Authors: KANMITCHELL J MUKAI T BARATELLI F WONGSTAAL F
Citation: J. Kanmitchell et al., MATURE MONOCYTE-DERIVED DENDRITIC CELLS TRANSDUCED BY A REPLICATION-DEFICIENT HIV-1 VECTOR ARE CAPABLE OF GENERATING HIV-SPECIFIC CYTOTOXICT-CELLS IN CULTURE, Journal of leukocyte biology, 1998, pp. 15-15
ANTI-HIV EFFECTS OF HIV VECTORS
Authors: CORBEAU P WONGSTAAL F
Citation: P. Corbeau et F. Wongstaal, ANTI-HIV EFFECTS OF HIV VECTORS, Virology, 243(2), 1998, pp. 268-274
A MINIMALLY REPLICATIVE HIV-2 LIVE-VIRUS VACCINE PROTECTS MACACA-NEMESTRINA FROM DISEASE AFTER HIV-2(287) CHALLENGE
Authors: LOONEY DJ MCCLURE J KENT SJ RADAELLI A KRAUS G SCHMIDT A STEFFY K GREENBERG P HU SL MORTON WR WONGSTAAL F
Citation: Dj. Looney et al., A MINIMALLY REPLICATIVE HIV-2 LIVE-VIRUS VACCINE PROTECTS MACACA-NEMESTRINA FROM DISEASE AFTER HIV-2(287) CHALLENGE, Virology, 242(1), 1998, pp. 150-160
SPECIFIC INTERACTION OF HTLV TAX PROTEIN AND A HUMAN TYPE-IV NEURONALINTERMEDIATE FILAMENT PROTEIN
Authors: REDDY TR LI XQ JONES Y ELLISMAN MH CHING GY LIEM RKH WONGSTAAL F
Citation: Tr. Reddy et al., SPECIFIC INTERACTION OF HTLV TAX PROTEIN AND A HUMAN TYPE-IV NEURONALINTERMEDIATE FILAMENT PROTEIN, Proceedings of the National Academy of Sciences of the United Statesof America, 95(2), 1998, pp. 702-707
IDENTIFICATION OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2) ENCAPSIDATION DETERMINANT AND TRANSDUCTION OF NONDIVIDING HUMAN-CELLS BY HIV-2-BASED LENTIVIRUS VECTORS
Authors: POESCHLA E GILBERT J LI XQ HUANG SA HO A WONGSTAAL F
Citation: E. Poeschla et al., IDENTIFICATION OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2) ENCAPSIDATION DETERMINANT AND TRANSDUCTION OF NONDIVIDING HUMAN-CELLS BY HIV-2-BASED LENTIVIRUS VECTORS, Journal of virology, 72(8), 1998, pp. 6527-6536
GENETIC-VARIATION IN A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 LIVE-VIRUSMACACA-NEMESTRINA VACCINE MODEL
Authors: RADAELLI A KRAUS G SCHMIDT A BADEL P MCCLURE J HU SL MORTON W MORGHEN CD WONGSTAAL F LOONEY D
Citation: A. Radaelli et al., GENETIC-VARIATION IN A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 LIVE-VIRUSMACACA-NEMESTRINA VACCINE MODEL, Journal of virology, 72(10), 1998, pp. 7871-7884
GENE-THERAPY TARGETING PERIPHERAL-BLOOD CD34(-CELLS OF HIV-INFECTED INDIVIDUALS() HEMATOPOIETIC STEM)
Authors: GERVAIX A SCHWARZ L LAW P HO AD LOONEY D LANE T WONGSTAAL F
Citation: A. Gervaix et al., GENE-THERAPY TARGETING PERIPHERAL-BLOOD CD34(-CELLS OF HIV-INFECTED INDIVIDUALS() HEMATOPOIETIC STEM), Human gene therapy, 8(18), 1997, pp. 2229-2238
FUNCTIONAL INTERACTION OF THE HTLV-1 TRANSACTIVATOR TAX WITH ACTIVATING TRANSCRIPTION FACTOR-IV (ATF4)
Authors: REDDY TR TANG HL LI XQ WONGSTAAL F
Citation: Tr. Reddy et al., FUNCTIONAL INTERACTION OF THE HTLV-1 TRANSACTIVATOR TAX WITH ACTIVATING TRANSCRIPTION FACTOR-IV (ATF4), Oncogene, 14(23), 1997, pp. 2785-2792
STRATEGIES FOR GENETIC INTERVENTION OF HIV REPLICATION
Authors: WONGSTAAL F
Citation: F. Wongstaal, STRATEGIES FOR GENETIC INTERVENTION OF HIV REPLICATION, The FASEB journal, 11(9), 1997, pp. 62-62
HIGHLIGHTS FROM THE UNIVERSITY-OF-CALIFORNIA SAN-DIEGO CENTER FOR AIDS RESEARCH
Authors: WONGSTAAL F
Citation: F. Wongstaal, HIGHLIGHTS FROM THE UNIVERSITY-OF-CALIFORNIA SAN-DIEGO CENTER FOR AIDS RESEARCH, AIDS research and human retroviruses, 13(2), 1997, pp. 117-120
IN-VITRO SELECTION OF ACTIVE HAIRPIN RIBOZYMES TO IDENTIFY OPTIMAL TARGET SITES WITHIN HCV RNA TRANSCRIPTS
Authors: KRUGER M TRITZ R WELCH PJ BARBER J MANNS MP WONGSTAAL F
Citation: M. Kruger et al., IN-VITRO SELECTION OF ACTIVE HAIRPIN RIBOZYMES TO IDENTIFY OPTIMAL TARGET SITES WITHIN HCV RNA TRANSCRIPTS, Hepatology, 26(4), 1997, pp. 514-514
IDENTIFICATION AND PURIFICATION OF CELLULAR PROTEINS THAT SPECIFICALLY INTERACT WITH THE RNA CONSTITUTIVE TRANSPORT ELEMENTS FROM RETROVIRUS-D
Authors: TANG HL XU Y WONGSTAAL F
Citation: Hl. Tang et al., IDENTIFICATION AND PURIFICATION OF CELLULAR PROTEINS THAT SPECIFICALLY INTERACT WITH THE RNA CONSTITUTIVE TRANSPORT ELEMENTS FROM RETROVIRUS-D, Virology, 228(2), 1997, pp. 333-339
A CELLULAR COFACTOR FOR THE CONSTITUTIVE TRANSPORT ELEMENT OF TYPE-D RETROVIRUS
Authors: TANG HL GAIETTA GM FISCHER WH ELLISMAN MH WONGSTAAL F
Citation: Hl. Tang et al., A CELLULAR COFACTOR FOR THE CONSTITUTIVE TRANSPORT ELEMENT OF TYPE-D RETROVIRUS, Science, 276(5317), 1997, pp. 1412-1415
A NEW REPORTER CELL-LINE TO MONITOR HIV-INFECTION AND DRUG SUSCEPTIBILITY IN-VITRO
Authors: GERVAIX A WEST D LEONI LM RICHMAN DD WONGSTAAL F CORBEIL J
Citation: A. Gervaix et al., A NEW REPORTER CELL-LINE TO MONITOR HIV-INFECTION AND DRUG SUSCEPTIBILITY IN-VITRO, Proceedings of the National Academy of Sciences of the United Statesof America, 94(9), 1997, pp. 4653-4658
MULTIGENE ANTIVIRAL VECTORS INHIBIT DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I CLADES
Authors: GERVAIX A LI XQ KRAUS G WONGSTAAL F
Citation: A. Gervaix et al., MULTIGENE ANTIVIRAL VECTORS INHIBIT DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I CLADES, Journal of virology, 71(4), 1997, pp. 3048-3053
INTRACELLULAR IMMUNIZATION OF RHESUS CD34(-CELLS AND MACROPHAGES FROMSIMIAN IMMUNODEFICIENCY VIRUS-INFECTION() HEMATOPOIETIC PROGENITOR CELLS WITH A HAIRPIN RIBOZYME PROTECTS T)
Authors: ROSENZWEIG M MARKS DF HEMPEL D HEUSCH M KRAUS G WONGSTAAL F JOHNSON RP
Citation: M. Rosenzweig et al., INTRACELLULAR IMMUNIZATION OF RHESUS CD34(-CELLS AND MACROPHAGES FROMSIMIAN IMMUNODEFICIENCY VIRUS-INFECTION() HEMATOPOIETIC PROGENITOR CELLS WITH A HAIRPIN RIBOZYME PROTECTS T), Blood, 90(12), 1997, pp. 4822-4831
GENE-THERAPY OF AIDS USING HEMATOPOIETIC-CELLS - PRECLINICAL EVALUATION OF MOBILIZATION AND TRANSDUCTION OF CD34(-INFECTED INDIVIDUALS() CELLS FROM HIV)
Authors: GERVAIX A SCHWARZ L LANE T LOONEY D YOUNG D RAMOS S HADRI P WONGSTAAL F HO AD LAW P
Citation: A. Gervaix et al., GENE-THERAPY OF AIDS USING HEMATOPOIETIC-CELLS - PRECLINICAL EVALUATION OF MOBILIZATION AND TRANSDUCTION OF CD34(-INFECTED INDIVIDUALS() CELLS FROM HIV), Blood, 90(10), 1997, pp. 4605-4605
SEVERE COMBINED IMMUNODEFICIENCY MICE ENGRAFTED WITH HUMAN T-CELLS, B-CELLS, AND MYELOID CELLS AFTER TRANSPLANTATION WITH HUMAN FETAL BONE-MARROW OR LIVER-CELLS AND IMPLANTED WITH HUMAN FETAL THYMUS - A MODEL FOR STUDYING HUMAN GENE-THERAPY
Authors: YURASOV S KOLLMANN TR KIM A RAKER CA HACHAMOVITCH M WONGSTAAL F GOLDSTEIN H
Citation: S. Yurasov et al., SEVERE COMBINED IMMUNODEFICIENCY MICE ENGRAFTED WITH HUMAN T-CELLS, B-CELLS, AND MYELOID CELLS AFTER TRANSPLANTATION WITH HUMAN FETAL BONE-MARROW OR LIVER-CELLS AND IMPLANTED WITH HUMAN FETAL THYMUS - A MODEL FOR STUDYING HUMAN GENE-THERAPY, Blood, 89(5), 1997, pp. 1800-1810
Risultati: 1-25 | 26-50 | 51-72